{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,4,16]],"date-time":"2023-04-16T10:17:14Z","timestamp":1681640234395},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,1,29]],"date-time":"2014-01-29T00:00:00Z","timestamp":1390953600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1007\/s10238-014-0273-x","type":"journal-article","created":{"date-parts":[[2014,1,28]],"date-time":"2014-01-28T14:56:39Z","timestamp":1390920999000},"page":"31-39","source":"Crossref","is-referenced-by-count":6,"title":["APL-2, an altered peptide ligand derived from heat-shock protein 60, induces interleukin-10 in peripheral blood mononuclear cell derived from juvenile idiopathic arthritis patients and downregulates the inflammatory response in collagen-induced arthritis model"],"prefix":"10.1007","volume":"15","author":[{"given":"Norailys","family":"Lorenzo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dolores","family":"Cantera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ariana","family":"Barber\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amaris","family":"Alonso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elsy","family":"Chall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lourdes","family":"Franco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julio","family":"Ancizar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanetsy","family":"Nu\u00f1ez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fiorella","family":"Altruda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenzo","family":"Silengo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel","family":"Padr\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"del Carmen Dominguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,1,29]]},"reference":[{"key":"273_CR1","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1186\/ar1485","volume":"7","author":"M Gattorno","year":"2005","unstructured":"Gattorno M, Prigione I, Morandi F et al (2005) Phenotypic and functional characterization of CCR7+ and CCR7\u2212 CD4+ memory T cells homing to the joints in juvenile idiopathic arthritis. Arthritis Res Ther 7:256\u2013267","journal-title":"Arthritis Res Ther"},{"key":"273_CR2","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1016\/S0140-6736(11)60244-4","volume":"377","author":"B Prakken","year":"2011","unstructured":"Prakken B, Se Albani, Martini A (2011) Juvenile idiopathic arthritis. Lancet 377:2138\u20132149","journal-title":"Lancet"},{"key":"273_CR3","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1136\/ard.2003.014886","volume":"63","author":"G Horneff","year":"2004","unstructured":"Horneff G, Schmeling H, Biedermann T et al (2004) The German etanercept registry for treatment of juvenile idiopathic arthritis. Ann Rheum Dis 63:1638\u20131644","journal-title":"Ann Rheum Dis"},{"key":"273_CR4","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/nri2138","volume":"7","author":"MG Rocarolo","year":"2007","unstructured":"Rocarolo MG, Battaglia M (2007) Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans. Nat Rev Immunol 7:585\u2013598","journal-title":"Nat Rev Immunol"},{"key":"273_CR5","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/nri1593","volume":"5","author":"W Eden van","year":"2005","unstructured":"van Eden W, van der Zee R, Prakken B (2005) Heat-shock proteins induce T-cell regulation of chronic inflammation. Nat Rev Immunol 5:318\u2013330","journal-title":"Nat Rev Immunol"},{"key":"273_CR6","first-page":"478","volume":"2","author":"PC Res","year":"1998","unstructured":"Res PC, Breedveld FC, van Embden JDA et al (1998) Synovial fluid T cell reactivity against 65\u00a0kDa heat shock protein of mycobacteria in early chronic arthritis. Lancet 2:478\u2013480","journal-title":"Lancet"},{"key":"273_CR7","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1016\/0140-6736(91)93057-G","volume":"337","author":"ER Graeff-Meeder de","year":"1991","unstructured":"de Graeff-Meeder ER, van der Zee R, Rijkers GT, Schuurman HJ, Kuis W et al (1991) Recognition of human 60\u00a0kD heat shock protein by mononuclear cells from patients with juvenile chronic arthritis. Lancet 337:1368\u20131372","journal-title":"Lancet"},{"key":"273_CR8","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1203\/00006450-199310000-00008","volume":"34","author":"ER Graeff-Meeder de","year":"1993","unstructured":"de Graeff-Meeder ER, Rijkers GT, Voorhorst-Ogink MM et al (1993) Antibodies to human Hsp60 in patients with juvenile chronic arthritis, diabetes mellitus, and cystic fibrosis. Pediatr Res 34:424\u2013428","journal-title":"Pediatr Res"},{"key":"273_CR9","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1002\/art.11174","volume":"48","author":"IM Kleer de","year":"2003","unstructured":"de Kleer IM, Kamphuis SM, Rijkers GT et al (2003) The spontaneous remission of juvenile idiopathic arthritis is characterized by CD30+ T cells directed to human heat-shock protein 60 capable of producing the regulatory cytokine interleukin-10. Arthritis Rheum 48:2001\u20132010","journal-title":"Arthritis Rheum"},{"key":"273_CR10","doi-asserted-by":"crossref","first-page":"6676","DOI":"10.1073\/pnas.1131898100","volume":"100","author":"M Paas-Rozner","year":"2003","unstructured":"Paas-Rozner M, Sela M, Mozes E (2003) A dual altered peptide ligand down-regulates myasthenogenic T cell responses by up-regulating CD25\u2212 and CTLA-4-expressing CD4+ T cells. Proc Natl Acad Sci USA 100:6676\u20136681","journal-title":"Proc Natl Acad Sci USA"},{"key":"273_CR11","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1073\/pnas.0409549102","volume":"102","author":"H Ben-David","year":"2005","unstructured":"Ben-David H, Sela M, Mozes E (2005) Down-regulation of myasthenogenic T cell response by a dual altered peptide ligand via CD4+ CD25+-regulated events leading to apoptosis. Proc Natl Acad Sci USA 102:2028\u20132033","journal-title":"Proc Natl Acad Sci USA"},{"key":"273_CR12","doi-asserted-by":"crossref","first-page":"3971","DOI":"10.1021\/jm8000554","volume":"51","author":"M Katsara","year":"2008","unstructured":"Katsara M, Deraos G, Tselios T et al (2008) Design of novel cyclic altered peptide ligands of myelin basic protein MBP83-99 that module immune responses in SJL\/J mice. J Med Chem 51:3971\u20133978","journal-title":"J Med Chem"},{"key":"273_CR13","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3109\/08916934.2010.550590","volume":"44","author":"MC Dom\u00ednguez","year":"2011","unstructured":"Dom\u00ednguez MC, Lorenzo N, Barbera A et al (2011) An altered peptide ligand corresponding to a novel epitope from heat-shock protein 60 induces regulatory T cells and suppresses pathogenic responses in an animal model of adjuvant induced arthritis. Autoimmunity 44:471\u2013482","journal-title":"Autoimmunity"},{"key":"273_CR14","doi-asserted-by":"crossref","first-page":"449","DOI":"10.3109\/08916934.2012.697592","volume":"45","author":"N Lorenzo","year":"2012","unstructured":"Lorenzo N, Barbera A, Dom\u00ednguez MC et al (2012) Therapeutic effect of an altered peptide ligand derived from heat-shock protein 60 by suppressing of inflammatory cytokines secretion in two animal models of rheumatoid arthritis. Autoimmunity 45:449\u2013459","journal-title":"Autoimmunity"},{"key":"273_CR15","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1056\/NEJMoa0706290","volume":"359","author":"DJ Lovell","year":"2008","unstructured":"Lovell DJ, Ruperto N, Goodman S et al (2008) Adalimumab with or without methotrexate in juvenile rheumatoid arthritis. N Engl J Med 359:810\u2013820","journal-title":"N Engl J Med"},{"key":"273_CR16","doi-asserted-by":"crossref","first-page":"3096","DOI":"10.1002\/art.22838","volume":"56","author":"N Ruperto","year":"2007","unstructured":"Ruperto N, Lovell DJ, Cuttica R et al (2007) A randomized, placebo-controlled trial of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis. Arthritis Rheum 56:3096\u20133106","journal-title":"Arthritis Rheum"},{"key":"273_CR17","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1002\/art.10885","volume":"48","author":"P Quartier","year":"2003","unstructured":"Quartier P, Taupin P, Bourdeaut F et al (2003) Efficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset type. Arthritis Rheum 48:1093\u20131101","journal-title":"Arthritis Rheum"},{"key":"273_CR18","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.semarthrit.2007.10.002","volume":"38","author":"SR Satpute","year":"2008","unstructured":"Satpute SR, Durai M, Moudgil KD (2008) Antigen-specific tolerogenic and immunomodulatory strategies for the treatment of autoimmune arthritis. Semin Arthritis Rheum 38:195\u2013207","journal-title":"Semin Arthritis Rheum"},{"key":"273_CR19","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1002\/art.24916","volume":"60","author":"EC Koffeman","year":"2009","unstructured":"Koffeman EC, Genovese M, Amox D et al (2009) Epitopo-specific immunotherapy of rheumatoid arthritis: clinical responsiveness occurs with immune deviation and relies on the expression of a cluster of molecules associated with T cell tolerance in a double-blind, placebo-controlled, pilot phase II trial. Arthritis Rheum 60:3207\u20133216","journal-title":"Arthritis Rheum"},{"key":"273_CR20","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.4049\/jimmunol.171.7.3533","volume":"171","author":"FJ Quintana","year":"2003","unstructured":"Quintana FJ, Carmi P, Mor F, Cohen IR (2003) DNA fragments of the human 60-kDa heat shock protein (HSP60) vaccinate against adjuvant arthritis: identification of a regulatory HSP60 peptide. J Immunol 171:3533\u20133541","journal-title":"J Immunol"},{"key":"273_CR21","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1172\/JCI200423396","volume":"114","author":"IR Cohen","year":"2004","unstructured":"Cohen IR, Quintana FJ, Mimran A (2004) Tregs in T cell vaccination: exploring the regulation of regulation. J Clin Investig 114:1227\u20131232","journal-title":"J Clin Investig"},{"key":"273_CR22","first-page":"46","volume":"7","author":"W Eden van","year":"2007","unstructured":"van Eden W, Prakken AB, Albani S (2007) Immunological tolerance in the therapy of rheumatoid arthritis. Discov Med 7:46\u201350","journal-title":"Discov Med"},{"key":"273_CR23","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S0140-6736(05)66827-4","volume":"366","author":"S Kamphuis","year":"2005","unstructured":"Kamphuis S, Kuis W, de Jager W et al (2005) Tolerogenic immune response to novel T-cell epitopes from heat-shock protein 60 in juvenile idiopathic arthritis. Lancet 366:50\u201356","journal-title":"Lancet"},{"key":"273_CR24","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1172\/JCI117801","volume":"95","author":"ER Graeff-Meeder de","year":"1995","unstructured":"de Graeff-Meeder ER, Van Eden W, Rijkers GT et al (1995) Juvenile chronic arthritis: T cell reactivity to human HSP60 in patients with a favourable course of arthritis. J Clin Investig 95:934\u2013940","journal-title":"J Clin Investig"},{"key":"273_CR25","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1002\/art.1780391108","volume":"39","author":"ABJ Prakken","year":"1996","unstructured":"Prakken ABJ, van Eden W, Rijkers GT et al (1996) Autoreactivity to human heat-shock protein 60 predicts disease remission in oligoarticular juvenile rheumatoid arthritis. Arthritis Rheum 39:1826\u20131832","journal-title":"Arthritis Rheum"},{"key":"273_CR26","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0896-8411(03)00047-7","volume":"20","author":"MG Roncarolo","year":"2004","unstructured":"Roncarolo MG, Battaglia M, Gregori S (2004) The role of interleukin 10 in the control of autoimmunity. J Autoimmun 20:269\u2013272","journal-title":"J Autoimmun"},{"key":"273_CR27","doi-asserted-by":"crossref","first-page":"6030","DOI":"10.4049\/jimmunol.169.10.6030","volume":"169","author":"FJ Quintana","year":"2002","unstructured":"Quintana FJ, Carmi P, Cohen IR (2002) DNA vaccination with heat shock protein 60 inhibits cyclophosphamide-accelerated diabetes. J Immunol 169:6030\u20136035","journal-title":"J Immunol"},{"key":"273_CR28","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.4049\/jimmunol.171.7.3533","volume":"171","author":"FJ Quintana","year":"2003","unstructured":"Quintana FJ, Carmi P, Mor F, Cohen IR (2003) DNA fragments of human HSP60 vaccinates againts adjuvant arthritis: Identification of regulatory HSP60 peptide. J Immunol 171:3533\u20133541","journal-title":"J Immunol"},{"issue":"5","key":"273_CR29","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1038\/nprot.2007.173","volume":"2","author":"DD Brand","year":"2007","unstructured":"Brand DD, Latham KA, Rosloniec EF (2007) Collagen-induced arthritis. Nat Protoc 2(5):1269\u20131275","journal-title":"Nat Protoc"},{"key":"273_CR30","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00296-008-0634-4","volume":"29","author":"J Zhao","year":"2008","unstructured":"Zhao J, Li R, He J et al (2008) Mucosal administration of an altered CII263-272 peptide inhibits collagen-induced arthritis by suppression of Th1\/Th17 cells and expansion of regulatory T cells. Rheumatol Int 29:9\u201316","journal-title":"Rheumatol Int"},{"key":"273_CR31","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1136\/ard.2006.057927","volume":"66","author":"ZQ Yao","year":"2007","unstructured":"Yao ZQ, Li R, Li ZG (2007) A triple altered collagen II peptide with consecutive substitutions of TCR contacting residues inhibits collagen-induced arthritis. Ann Rheum Dis 66:423\u2013424","journal-title":"Ann Rheum Dis"},{"key":"273_CR32","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.clim.2005.09.020","volume":"118","author":"R Li","year":"2006","unstructured":"Li R, Li X, Li Z (2006) Altered collagen II peptides inhibited T-cell activation in rheumatoid arthritis. Clin Immunol 118:317\u2013323","journal-title":"Clin Immunol"},{"key":"273_CR33","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1056\/NEJMct055183","volume":"355","author":"DL Scott","year":"2006","unstructured":"Scott DL, Kingsley GH (2006) Tumor necrosis factors inhibitors for rheumatoid arthritis. N Engl J Med 355:704\u2013712","journal-title":"N Engl J Med"},{"key":"273_CR34","first-page":"904","volume":"344","author":"EH Choy","year":"2001","unstructured":"Choy EH, Panayi GS (2001) Cytokine pathways and joint inflammation in rheumatoid arthritis. N Engl J Med 344:904\u2013916","journal-title":"N Engl J Med"},{"key":"273_CR35","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.2174\/0929867043364694","volume":"11","author":"I Carpentier","year":"2004","unstructured":"Carpentier I, Coormaert B, Beyaert R (2004) Function and regulation of tumor necrosis factor type 2. Curr Med Chem 11:2205\u20132212","journal-title":"Curr Med Chem"},{"key":"273_CR36","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1038\/ni1261","volume":"6","author":"H Park","year":"2005","unstructured":"Park H, Li Z, Yang XO et al (2005) A distinct lineage of CD4 T cells regulate tissue inflammation by producing interleukin 17. Nat Immunol 6:1133\u20131141","journal-title":"Nat Immunol"},{"key":"273_CR37","doi-asserted-by":"crossref","first-page":"6173","DOI":"10.4049\/jimmunol.171.11.6173","volume":"171","author":"S Nakae","year":"2003","unstructured":"Nakae S, Nambu A, Sudo K, Iwakura Y (2003) Suppression of immune induction of collagen-induced arthritis in IL-17-Deficient Mice. J Immunol 171:6173\u20136177","journal-title":"J Immunol"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-014-0273-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10238-014-0273-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-014-0273-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T03:06:44Z","timestamp":1565147204000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10238-014-0273-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,29]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["273"],"URL":"https:\/\/doi.org\/10.1007\/s10238-014-0273-x","relation":{},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,29]]}}}